Literature DB >> 24165975

LPS-induced effects on angiotensin I-converting enzyme expression and shedding in human pulmonary microvascular endothelial cells.

M I Hermanns1, A M Müller, M Tsokos, C J Kirkpatrick.   

Abstract

Angiotensin I-converting enzyme (kininase II, ACE, and CD143) availability is a determinant of local angiotensin and kinin concentrations and their physiological actions. Until now, it is unclear whether the decrease of pulmonary ACE activity in sepsis-described in clinical studies-is due to an enzyme compensatory downregulation (reduced ACE-mRNA expression) to shedding of ACE or endothelial damage. To address these questions, ACE distribution under septic conditions was studied in vitro by treating pulmonary microvascular endothelial cells (HPMEC) and human umbilical vein endothelial cells (HUVEC) with lipopolysaccharide from Escherichia coli (LPS). Primary isolated HUVEC and HPMEC were compared by detecting ACE activity, membrane-bound ACE, as well as shedding and mRNA production of ACE with and without LPS (1 ng/ml-1 μg/ml). ACE mRNA expression was detected by real-time PCR, and shedded ACE was measured in cell culture supernatant by ELISA. Additionally, membrane-bound protein expression was investigated by immunohistochemistry in situ. In septic ARDS, the distribution of ACE protein was significantly reduced in all lung endothelial cells (p<0.001). After stimulation with LPS, cultivated HPMEC showed more markedly than HUVEC, a concentration-dependent reduction of ACE protein expression compared to the respective untreated controls. Real-time PCR demonstrated a reduced ACE mRNA expression after LPS stimulation, predominantly in HPMEC. Specifically, in HPMEC, a concentration-dependent increase of shedded ACE was shown 24 h after LPS treatment. HPMEC cultures are an apt model for the investigation of pulmonary ACE expression in sepsis. This study suggests that reduced pulmonary microvascular endothelial ACE expression in septic ARDS is caused by two processes: (initial) increased shedding of ACE accompanied by a compensatory downregulation of ACE-mRNA and membrane-bound protein expression.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24165975     DOI: 10.1007/s11626-013-9707-0

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN: 1071-2690            Impact factor:   2.416


  42 in total

1.  Endothelial ectoenzyme assays estimate perfused capillary surface area in the dog lung.

Authors:  S E Orfanos; I C Ehrhart; S Barman; W F Hofman; J D Catravas
Journal:  Microvasc Res       Date:  1997-09       Impact factor: 3.514

Review 2.  2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference.

Authors:  Mitchell M Levy; Mitchell P Fink; John C Marshall; Edward Abraham; Derek Angus; Deborah Cook; Jonathan Cohen; Steven M Opal; Jean-Louis Vincent; Graham Ramsay
Journal:  Crit Care Med       Date:  2003-04       Impact factor: 7.598

3.  Induction of stress proteins in human endothelial cells by heavy metal ions and heat shock.

Authors:  M Wagner; I Hermanns; F Bittinger; C J Kirkpatrick
Journal:  Am J Physiol       Date:  1999-11

Review 4.  Endothelial function studies in pulmonary vascular disease: determination of angiotensin converting enzyme activity in humans (review).

Authors:  Attila Cziráki; Iván G Horváth; Lajos Papp
Journal:  Int J Mol Med       Date:  2002-03       Impact factor: 4.101

5.  Incidence and outcomes of acute lung injury.

Authors:  Gordon D Rubenfeld; Ellen Caldwell; Eve Peabody; Jim Weaver; Diane P Martin; Margaret Neff; Eric J Stern; Leonard D Hudson
Journal:  N Engl J Med       Date:  2005-10-20       Impact factor: 91.245

6.  Endotoxin reduces specific pulmonary uptake of radiolabeled monoclonal antibody to angiotensin-converting enzyme.

Authors:  V R Muzykantov; E A Puchnina; E N Atochina; H Hiemish; M A Slinkin; F E Meertsuk; S M Danilov
Journal:  J Nucl Med       Date:  1991-03       Impact factor: 10.057

7.  Angiotensin converting enzyme insertion/deletion polymorphism is associated with susceptibility and outcome in acute respiratory distress syndrome.

Authors:  Richard P Marshall; Suzanne Webb; Geoffrey J Bellingan; Hugh E Montgomery; Babar Chaudhari; Robin J McAnulty; Steve E Humphries; Mike R Hill; Geoffrey J Laurent
Journal:  Am J Respir Crit Care Med       Date:  2002-09-01       Impact factor: 21.405

8.  Responses of serum and lung angiotensin-converting enzyme activities in the early phase of pulmonary damage induced by oleic acid in dogs.

Authors:  T Nukiwa; R Matsuoka; H Takagi; Y Ishii; T Arai; S Kira
Journal:  Am Rev Respir Dis       Date:  1982-12

9.  Angiotensin-converting enzyme inhibitor captopril prevents oleic acid-induced severe acute lung injury in rats.

Authors:  Xiaolin He; Bing Han; Marco Mura; Shuyue Xia; Shi Wang; Tao Ma; Mingyao Liu; Zhi Liu
Journal:  Shock       Date:  2007-07       Impact factor: 3.454

10.  Effects of an angiotensin-converting enzyme inhibitor on the inflammatory response in in vivo and in vitro models.

Authors:  Satoshi Hagiwara; Hideo Iwasaka; Shigekiyo Matumoto; Seigo Hidaka; Takayuki Noguchi
Journal:  Crit Care Med       Date:  2009-02       Impact factor: 7.598

View more
  4 in total

1.  Local corticosterone production and angiotensin-I converting enzyme shedding in a mouse model of intestinal inflammation.

Authors:  Hanne Salmenkari; Tomi Issakainen; Heikki Vapaatalo; Riitta Korpela
Journal:  World J Gastroenterol       Date:  2015-09-21       Impact factor: 5.742

2.  Key Molecular Mechanisms of Chaiqinchengqi Decoction in Alleviating the Pulmonary Albumin Leakage Caused by Endotoxemia in Severe Acute Pancreatitis Rats.

Authors:  Wei Wu; Ruijie Luo; Ziqi Lin; Qing Xia; Ping Xue
Journal:  Evid Based Complement Alternat Med       Date:  2016-06-19       Impact factor: 2.629

Review 3.  Endothelial Damage in Acute Respiratory Distress Syndrome.

Authors:  Alice G Vassiliou; Anastasia Kotanidou; Ioanna Dimopoulou; Stylianos E Orfanos
Journal:  Int J Mol Sci       Date:  2020-11-20       Impact factor: 5.923

Review 4.  Covid-19 and the Renin Angiotensin System: Implications for the Older Adults.

Authors:  G Bahat
Journal:  J Nutr Health Aging       Date:  2020       Impact factor: 5.285

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.